A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

NCT05593029 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

929

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: SEP-363856
OTHER: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.